The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy in Patients With Chronic Obstructive Pulmonary Disease (COPD) III-IV

The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy on Dyspnoea and Activity in Patients With COPD III-IV

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01478646

Enrollment

Registered

2011-11-23

Start date

2011-08-31

Completion date

2011-11-30

Last updated

2011-11-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

breathing therapy, reflective breathing therapy, COPD, chronic obstructive pulmonary disease

Brief summary

The purpose of this study is to determine whether different types of breathing therapies in patients with COPD III-IV decrease dyspnea and increase activity.

Detailed description

In the treatment of COPD-Patients different kinds of breathing therapy techniques are used, but many of them are not reassessed yet. Dyspnea is one of the predominant symptoms of COPD patients and has negative impacts on the activity of the patients. Dyspnea during exertion leads to avoiding activity and results in a deconditioning of muscles and of the cardiovascular system. Thus breathing therapy techniques seem to be useful, which may lead to a decrease of dyspnea and an increase of activity. The purpose of this study is to determine whether reflective breathing therapy is more effective on decreasing dyspnea and increasing activity than conventional breathing therapy.

Interventions

OTHERconventional breathing therapy

duration: 60 minutes.

OTHERreflectory breathing therapy

duration: 60 minutes.

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

45 Years to 75 Years

Healthy volunteers

Inclusion criteria

* inpatient rehabilitation * COPD (Gold stage III and IV)

Exclusion criteria

* severe exacerbation in the last four weeks * acute infections * fever * neuritides * severe osteoporosis * skin disease * manic depression

Design outcomes

Primary

Measure	Time frame	Description
Change in BORG-Scale	Change from pre (minute o) in BORG-scale at directly post intervention (minute 60)	Instrument for self-reported dyspnea; modified BORG-scale ranges from 1 (no dyspnea) to 10 (maximum dyspnea).

Secondary

Measure	Time frame	Description
Change in residual volume	change from pre (minute 0) in residual volume at post (minute 60) intervention	measured by a portable spirometry device

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026